Latest News

MARA Holdings, Inc. recently reported full-year 2025 results showing sales rising to US$907.09 million from US$656.38 million, while moving from net income of US$541.25 million to a net loss of US$1,311.48 million, alongside a new agreement with Starwood Capital to convert select power-rich sites into AI-ready data centers. This combination of a sharp swing into losses and a pivot toward AI and high-performance compute marks a material reshaping of MARA’s business mix and risk profile, as it...

Techtronic Industries (SEHK:669) has drawn investor attention after recent share price swings, with the stock showing mixed short term moves alongside longer term gains that invite a closer look at its fundamentals. See our latest analysis for Techtronic Industries. The recent 1 day share price return of 2.0% decline and 7 day share price return of 6.7% decline sit against a 30 day share price return of 4.8% and 90 day share price return of 24.1%. At the same time, the 1 year total...

If you are wondering whether Dell Technologies is actually worth its current share price, you are not alone. This article is designed to help you weigh what you are really paying for. The stock last closed at US$146.52, with reported returns of 20.6% over 7 days, 25.1% over 30 days, 14.6% year to date and 60.4% over 1 year, plus a 3 year gain of 311.1% and 5 year gain of 258.1% that many investors are trying to put into context. Recent coverage of Dell has focused on its position within the...

Tenet Healthcare (THC) has drawn fresh investor attention after recent share price moves, with the stock’s one-month and past three-month returns standing out against its own longer-term performance profile. See our latest analysis for Tenet Healthcare. Set against a softer 1 day share price return of 1.39% and a modest 7 day gain of 0.72%, Tenet Healthcare’s 30 day share price return of 25.17% and 1 year total shareholder return of 92.44% suggest that momentum has been building over both...

JINGDONG Industrials (SEHK:7618) has just laid out its FY 2025 scorecard, with first half revenue of CN¥10.3b and basic EPS of CN¥0.22 setting the tone for how the year is shaping up against a current share price of CN¥11.47. The company has reported revenue of CN¥8.6b and EPS of CN¥0.14 in 1H 2024, CN¥11.8b and EPS of CN¥0.23 in 2H 2024, and CN¥10.3b and EPS of CN¥0.22 in 1H 2025, while trailing twelve month figures show CN¥23.0b in revenue and EPS of CN¥1.12. With net margin over the last...

American Airlines Group (NasdaqGS:AAL) is dealing with flight disruptions linked to escalating conflict in the Middle East, affecting routes and capacity in the region. Recent spikes in oil prices are pressuring the airline's fuel bill, with the impact amplified by the company’s lack of fuel hedging and existing financial leverage. Analysts have issued downgrades that cite these operational and cost risks, adding to investor concern about the company’s profitability outlook. American...

Wondering if Moody's current share price lines up with its underlying worth, or if the market is mispricing it right now? This article walks through the numbers so you can judge the value story for yourself. The stock last closed at US$470.05, with returns of a 2.0% decline over 7 days, a 0.2% decline over 30 days, a 5.8% decline year to date, 0.8% over 1 year, 63.3% over 3 years and 68.1% over 5 years. This gives a mixed picture of short term softness and longer term strength. Recent...

If you are wondering whether Nomad Foods at US$10.33 is starting to look like value or a value trap, you are not alone. That is exactly what this article will unpack. The stock has seen an 8.3% decline over the last week, an 18.0% drop over the past month, and is down 47.0% over the past year, putting long term holders under pressure and raising fresh questions about risk and return. Recent coverage has focused on how prolonged share price weakness and earlier acquisition activity have...

Earnings jolt puts Topicus.com (TSXV:TOI) margins in focus Topicus.com (TSXV:TOI) has just reported full year 2025 results, with revenue of €1,552.3 million and net income of €41.76 million, compared with €1,294.86 million and €91.99 million a year earlier. That mix of higher sales and lower earnings per share, from €1.11 to €0.50, gives investors fresh numbers to reassess how the company’s growth, profitability, and valuation line up today. See our latest analysis for Topicus.com. The latest...

Shelf registration puts UnitedHealth’s funding options in focus UnitedHealth Group (UNH) has filed an omnibus shelf registration covering debt, preferred stock, common stock, and warrants. The filing puts fresh attention on how the company might adjust its capital structure as it works through recent operating and regulatory challenges. See our latest analysis for UnitedHealth Group. At a share price of US$288.77, UnitedHealth’s 90 day share price return of 12.73% and year to date share price...

Johnson Controls International (NYSE:JCI) has agreed to acquire Alloy Enterprises to expand its data center thermal management capabilities. The deal is aimed at strengthening Johnson Controls' position in advanced cooling solutions as data center demand increases. The acquisition focuses on adding new technology for more efficient thermal management across data-centric infrastructure. Johnson Controls International, trading on the NYSE under ticker JCI, is moving to deepen its presence in...

What recent performance tells you about MDA Space MDA Space (TSX:MDA) has been on the radar for many investors after a strong run, with the share price moving higher over the past month and past 3 months, despite a 3% decline in the last trading day. That recent pullback comes after sizeable longer term gains, including an 83% total return over the past year and a very large 3 year total return, which may prompt some holders to reassess position size and risk. See our latest analysis for MDA...

Ambiq Micro (AMBQ) just closed out FY 2025 with Q4 revenue of US$20.7 million and a basic EPS loss of US$0.58, alongside net income excluding extra items of a US$10.7 million loss, putting profitability squarely in focus for investors. The company has seen quarterly revenue hover in the mid to high teens over the past year, from US$15.7 million in Q1 FY 2025 to US$18.2 million in Q3, while basic EPS losses ranged from US$18.96 in Q1 FY 2025 to US$26.40 in Q4 FY 2024 before landing at US$0.58...

If you are wondering whether Blackbaud's current share price reflects its real worth, you are not alone. This article is set up to help you weigh what you are paying against what you might be getting. Over the short term the stock has seen relatively small moves, with a 1.0% return over 7 days and 1.5% over 30 days, while year to date it is down 17.2% and over 1 year it is down 23.7%. These figures may influence how you think about both risk and potential reward. Recent headlines around...

Vericel Corporation recently received U.S. Food and Drug Administration approval to begin commercial manufacturing of its MACI cartilage repair therapy at a new cell therapy facility in Burlington, Massachusetts, enabling production to start in the second quarter of 2026. This expansion of MACI manufacturing capacity is important because it supports higher volumes for knee cartilage repair and lays groundwork for potential international commercialization. Next, we’ll explore how FDA approval...

Marvell Technology, Inc. has reported past fourth-quarter 2026 revenue of US$2,218.7 million and net income of US$396.1 million, with full-year revenue of US$8.19 billion and net income of US$2.67 billion, and issued first-quarter fiscal 2027 guidance calling for about US$2.40 billion in net revenue and GAAP diluted EPS of roughly US$0.31. Alongside these results, Marvell unveiled new 2nm coherent DSPs and 1.6T ZR/ZR+ optical modules aimed at AI data center connectivity, reinforcing its...

Phillips 66 (PSX) has come into focus after lifting its quarterly dividend to $1.27 per share and outlining plans to improve refining feedstock costs through potential Venezuelan crude purchases, as oil prices and refining margins tighten. See our latest analysis for Phillips 66. The dividend move comes on top of strong recent price momentum, with a 19.4% 3 month share price return and a 27.5% year to date share price return, while the 5 year total shareholder return of 129.9% points to solid...

If you are wondering whether Estée Lauder Companies at around US$95.87 is a bargain or a value trap, you are not alone. This article is aimed at helping you frame that question clearly. The stock has seen a mixed run, with a 14.3% decline over the last 7 days and a 17.5% decline over the last 30 days. Yet a 36.1% gain over the past year sits against 3 year and 5 year returns of 58.4% and 64.6% declines respectively. Recent headlines have focused on Estée Lauder Companies as a key global...

If you are wondering whether BlackBerry at around CA$4.84 is a bargain or a value trap, you are not alone. The answer depends heavily on how you look at valuation. The share price has moved 0.8% over the last 7 days and 4.3% over the last 30 days. Yet year to date it is down 7.3% and over 1 year it has returned negative 23.4%, which can change how investors think about both risk and potential upside. Recent coverage around BlackBerry has focused on its evolution from its handset past toward...

SBA Communications (SBAC) has drawn fresh attention after recent trading data showed a gain of about 9% over the past month, prompting investors to reassess the tower REIT’s current valuation and fundamentals. See our latest analysis for SBA Communications. That recent 8.9% 30 day share price return contrasts with a 1 year total shareholder return of about an 8.7% decline, which suggests that momentum has picked up recently even though longer term holders are still behind. If SBA...

If you are wondering whether Primoris Services is still good value after its strong run, you are not alone. This article focuses squarely on what you are paying for each dollar of the business. The share price recently closed at US$137.91, with returns of 117.8% over 1 year and 5.6% year to date, and pullbacks of 9.3% over 7 days and 11.0% over 30 days that hint at shifting views on both upside and risk. Recent coverage of Primoris Services has focused on its position within the US capital...

Generate Biomedicines completed its U.S. IPO and began trading on Nasdaq under the symbol GENB. The company adopted a new certificate of incorporation in connection with its transition to public status. Generate Biomedicines joined the NASDAQ Composite Index following the offering. The IPO involved a substantial capital raise intended to support the company’s future plans. Generate Biomedicines, now trading as NasdaqGS:GENB, has moved into the public markets with a current share price of...

Micron Technology (MU) is back in focus after a sharp sector wide selloff tied to fears of higher energy costs and Iran related tensions, which pressured memory names despite ongoing AI centric demand stories. See our latest analysis for Micron Technology. Despite the latest pullback tied to energy concerns and geopolitical tensions, Micron’s recent share price performance has been strong, with a 90 day share price return of 67.38% and a very large 1 year total shareholder return of 328.52%...

Symrise (XTRA:SY1) shares are in focus after the company paired its 2025 results with a proposed dividend increase, a new Care & Wellness division, and a €400 million share buyback program. See our latest analysis for Symrise. At a share price of €72.68, Symrise has a 1-day share price return of 2.45% and a year to date share price return of 6.32%. However, the 1-year total shareholder return of 23.13% and 5-year total shareholder return of 24.66% show that longer term holders have faced...